Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Aptevo Therapeutics (APVO) Short-term Investments (2016 - 2021)

Historic Short-term Investments for Aptevo Therapeutics (APVO) over the last 6 years, with Q3 2021 value amounting to $1.3 million.

  • Aptevo Therapeutics' Short-term Investments fell 5072.41% to $1.3 million in Q3 2021 from the same period last year, while for Sep 2021 it was $1.3 million, marking a year-over-year decrease of 5072.41%. This contributed to the annual value of $2.6 million for FY2020, which is N/A changed from last year.
  • Per Aptevo Therapeutics' latest filing, its Short-term Investments stood at $1.3 million for Q3 2021, which was down 5072.41% from $1.3 million recorded in Q2 2021.
  • In the past 5 years, Aptevo Therapeutics' Short-term Investments ranged from a high of $73.7 million in Q4 2017 and a low of $1.3 million during Q1 2021
  • In the last 5 years, Aptevo Therapeutics' Short-term Investments had a median value of $7.5 million in 2018 and averaged $18.6 million.
  • As far as peak fluctuations go, Aptevo Therapeutics' Short-term Investments skyrocketed by 6430.24% in 2017, and later crashed by 8989.25% in 2018.
  • Over the past 5 years, Aptevo Therapeutics' Short-term Investments (Quarter) stood at $73.7 million in 2017, then tumbled by 89.89% to $7.4 million in 2018, then increased by 0.67% to $7.5 million in 2019, then plummeted by 65.92% to $2.6 million in 2020, then plummeted by 50.72% to $1.3 million in 2021.
  • Its Short-term Investments stands at $1.3 million for Q3 2021, versus $1.3 million for Q2 2021 and $1.3 million for Q1 2021.